Literature DB >> 698731

Intensive iron-chelation in thalassaemia.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 698731      PMCID： PMC1607825          DOI： 10.1136/bmj.2.6140.782

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

1.  CARDIAC INVOLVEMENT IN COOLEY'S ANEMIA.

Authors:  M A ENGLE
Journal:  Ann N Y Acad Sci       Date:  1964-10-07       Impact factor: 5.691

2.  Continuous subcutaenous administration of deferoxamine in patients with iron overload.

Authors:  R D Propper; B Cooper; R R Rufo; A W Nienhuis; W F Anderson; H F Bunn; A Rosenthal; D G Nathan
Journal:  N Engl J Med       Date:  1977-08-25       Impact factor: 91.245

3.  Long-term desferrioxamine therapy in thalassemia.

Authors:  C B Modell; J Beck
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

4.  Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.

Authors:  M A Hussain; N Green; D M Flynn; S Hussein; A V Hoffbrand
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321

5.  Long-term chelation therapy in thalassaemia major: effect on liver iron concentration, liver histology, and clinical progress.

Authors:  M Barry; D M Flynn; E A Letsky; R A Risdon
Journal:  Br Med J       Date:  1974-04-06

6.  Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias.

Authors:  M J Pippard; S T Callender; D J Weatherall
Journal:  Clin Sci Mol Med       Date:  1978-01

7.  Reassessment of the use of desferrioxamine B in iron overload.

Authors:  R D Propper; S B Shurin; D G Nathan
Journal:  N Engl J Med       Date:  1976-06-24       Impact factor: 91.245

8.  Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.

Authors:  M A Hussain; N Green; D M Flynn; A V Hoffbrand
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

9.  Prevention of iron loading in transfusion-dependent thalassaemia.

Authors:  M J Pippard; E A Letsky; S T Callender; D J Weatherall
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

10.  Iron chelation therapy with deferoxamine in Cooley anemia.

Authors:  A Cohen; E Schwartz
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.